Semaglutide is a newer injectable drug approved by the Food and Drug Administration (FDA) to help obese adults lose weight and keep it off. It is manufactured by Novo Nordisk, which also manufactures Victoza. Semaglutide weight loss works through GLP-1 agonism, or the stimulation of glucagon-like peptide 1 receptors in your intestines. When these receptors are activated, your body experiences a drop in appetite as well as an increase in blood sugar, among other things.Semaglutide is different from other weight loss treatments out there because of how it is administered and the fact that it is FDA approved. Semaglutide must be injected subcutaneously. It was also found to improve blood sugar in people with type 2 diabetes and can help control blood sugar in combination with other diabetes treatment you may be using, like sulfonylurea or insulin.Semaglutide is not used as an anti-diabetic medicine on its own but rather along with these other drugs to help manage your blood sugar. Because semaglutide works by manipulating your body’s GLP-1 levels, it isn’t able to give you any immediate effects after taking it, meaning that you won’t feel satisfied until a few hours later when its effects start working on your system. This may take some getting used to if you are transitioning off fast-acting diet pills or something similar.

Tirzepatide is an innovative drug used for weight control. It mimics two important hormones, GLP-1 and GIP, which help regulate blood sugar levels and control appetite. This dual action leads to improved glucose control, reduced cravings, and significant weight loss. In clinical trials, tirzepatide has shown remarkable results in reducing HbA1c (a long-term measure of blood sugar) and helping patients lose substantial amounts of weight.

Semaglutide is a new drug in development that targets obesity. It’s a long-acting version of a hormone naturally produced by your pancreas called glucagon-like peptide-1, or GLP-1. When you eat, your stomach and intestines produce GLP-1 and it does two things: First, it slows down how quickly food leaves your stomach after you eat it, making you feel fuller longer. Second, it stimulates the production of insulin from your pancreas so that when nutrients from the food enter your bloodstream they can be used to generate energy rather than stored as fat under your skin.Semaglutide works by stimulating receptors in your digestive tract. These receptors send a message to your brain telling it you’re full, which results in decreased food intake and body fat loss. This is why taking semaglutide as part of an exercise program is often recommended—when working out, you get even more stimulation of these receptors and greater benefits overall.

Tirzepatide works for weight loss by targeting two key hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), both of which regulate appetite and glucose metabolism. By combining these effects, Tirzepatide promotes a steady reduction in body weight over time, making it highly effective for weight loss management.

That depends on how much you weigh to begin with, your medical history, and whether or not you have diabetes. For example, some people who weigh 200 pounds and take Semaglutide may lose about 20 pounds in a year. Some people who weigh 150 pounds may lose about 16 pounds in a year. If you’re overweight and have no other risk factors (like diabetes), talk to your doctor to see if Semaglutide is right for you. But note that it’s not a magical potion. Semaglutide works in combination with diet, exercise, and other prescription weight-loss medication if needed.

The amount of weight loss with Tirzepatide can vary depending on the dose and individual factors, but clinical trials have shown significant results. In a major study (SURMOUNT-1), participants lost 15% to 20% of their body weight over 72 weeks on higher doses (10 mg or 15 mg). This can translate to around 35 to 50 pounds or more for someone who weighs 250 pounds at the start. These results are quite substantial compared to other weight loss medications.

Yes, Semaglutide lowers blood sugar. Semaglutide is an incretin mimetic that works by increasing insulin secretion and suppressing glucagon release and the Tirzepatide works by mimicking the effects of two hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which help regulate insulin and blood sugar levels after eating. This dual action helps the body produce more insulin when needed and reduces the amount of sugar produced by the liver, effectively lowering blood sugar.